CancerCompass message board discussion started by YanaMom on 5/1/2008 http://www.cancercompass.com/message-board/message/all,23607,0.htm Thu, 24 Jul 2008 00:00:00 GMT Thu, 24 Jul 2008 00:00:00 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ http://www.oncologystat.com/journals/journal_scans/High-dose can it be done after revlimid-dex-dox? YanaMom Thu, 01 May 2008 00:00:00 GMT Good Morning Yanamom;"Although the patients treated with a TTP regimen were healthier prior to transplantation than were those in the other groups, the 92-month OS is still a remarkable achievement. Patients who achieved a CR or underwent a second transplant also had more favorable results. The authors thus recommend that patients be treated according to an established protocol, and if possible, receive the TTP-3 regimen."I reviewed the link you posted but couldn't find anything more concerning what is involved with the TTP-3 Regimen. Can you help me?Take care;Kevin K. C. Thu, 01 May 2008 00:00:00 GMT  On 5/1/2008 K. C. wrote:Good Morning Yanamom;"Although the patients treated with a TTP regimen were healthier prior to transplantation than were those in the other groups, the 92-month OS is still a remarkable achievement. Patients who achieved a CR or underwent a second transplant also had more favorable results. The authors thus recommend that patients be treated according to an established protocol, and if possible, receive the TTP-3 regimen."I reviewed the link you posted but couldn't find anything more concerning what is involved with the TTP-3 Regimen. Can you help me?Take care;Kevinyou got me there. have a look here: I think the key is in the investigator conclusions, though it is mostly greek to me.http://www.meds.com/conrad/ash/powles.html  though a bit of digging at the UAMS page revealed stage 2 trialhttp://myeloma.uams.edu/about-myeloma/swog_0115.asp Now I am extremely confused. At least this trial appears in both previously untreated and previously treated sections. But the article gives an impression of finished trials. frustrated. YanaMom Thu, 01 May 2008 00:00:00 GMT http://multiplemyeloma.org/treatments/3.03.05.php  Maybe this link would be clearer.  On 5/1/2008 YanaMom wrote: On 5/1/2008 K. C. wrote:Good Morning Yanamom;"Although the patients treated with a TTP regimen were healthier prior to transplantation than were those in the other groups, the 92-month OS is still a remarkable achievement. Patients who achieved a CR or underwent a second transplant also had more favorable results. The authors thus recommend that patients be treated according to an established protocol, and if possible, receive the TTP-3 regimen."I reviewed the link you posted but couldn't find anything more concerning what is involved with the TTP-3 Regimen. Can you help me?Take care;Kevinyou got me there. have a look here: I think the key is in the investigator conclusions, though it is mostly greek to me.http://www.meds.com/conrad/ash/powles.html  though a bit of digging at the UAMS page revealed stage 2 trialhttp://myeloma.uams.edu/about-myeloma/swog_0115.asp Now I am extremely confused. At least this trial appears in both previously untreated and previously treated sections. But the article gives an impression of finished trials. frustrated.  mmsurvivor Thu, 01 May 2008 00:00:00 GMT Thank you - it helped. YanaMom Fri, 02 May 2008 00:00:00 GMT